Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Cancer Pain × Sugars × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 3 Breast Neoplasms 3 Neoplasms 2 Vomiting 1 Peripheral Nervous System Diseases 1 Periampullary Carcinoma Nos 1 Pediatric Crohn's disease 1 Pain 1 Nausea 1 Myasthenia Gravis 1 Memory Disorders 1 Leiomyoma 1 Hot Flashes 1 Fatigue 1 Cognitive Dysfunction 1 Cancer Pain 1 Anemia 1

Interventions

Morphine 5 nabiximols 3 Oxycodone 2 Methadone 2 Hydromorphone 2 Acetaminophen 2 tanezumab 1 resiniferatoxin 1 naloxegol 1 Tapentadol 1 Sugars 1 Standard of Care 1 Lidocaine 1 Inosine Monophosphate 1 Fentanyl 1 Donepezil 1 6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00152854 2016-03-08

Acetaminophen for Cancer Pain

University Health Network, Toronto

Phase 3 Completed

Cancer Pain, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡